Company Profiles

driven by the PitchBook Platform

Excelimmune

Description

Operator of a bio-pharmaceutical company designed to leverage the diversity, specificity and power of the human body's natural immune system. The company's pharmaceutical includes discovery and development of antibody combination therapeutics, enabling infectious diseases, protein diseases and cancer.

2006

Founded

PRIVATE

Status

1-10

Employees

Debt

Latest Deal Type

$6M

Latest Deal Amount

$14.5M

Total Amount Raised

Description

Operator of a bio-pharmaceutical company designed to leverage the diversity, specificity and power of the human body's natural immune system. The company's pharmaceutical includes discovery and development of antibody combination therapeutics, enabling infectious diseases, protein diseases and cancer.

Website:

www.excelimmune.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

1776 Massachusetts Avenue Lexington, MA 02420United States +1 (781) 262-8055
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Excelimmune's full profile, request a free trial.

    Excelimmune Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Excelimmune Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Excelimmune Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    David JeskeAngel (individual)Minority000 0000000 0000
    GreenheartVenture CapitalMinority000 0000000 0000
    Individual InvestorAngel (individual)Minority000 0000000 0000
    David Jeske Angel (individual)
    Greenheart Venture Capital
    Individual Investor Angel (individual)

    Excelimmune Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Thomas Dahl Ph.DVice President, Product Development
    Jason WalshChief Financial Officer & Vice President, Corporate Development
    Thomas Dahl Ph.D Vice President, Product Development
    Jason Walsh Chief Financial Officer & Vice President, Corporate Development

    Excelimmune Board Members (1)

    NameRepresentingRoleSinceContact
    Info
    Mark De Souza Ph.DSelfDirector000 0000
    Mark De Souza Ph.D Director Self
    Request full access to PitchBook